OpenEvidence America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
OpenEvidence launches Coding Intelligence™ to help physicians capture . . . Miami, FL (March 24, 2026) — OpenEvidence, the most widely used medical AI and clinical decision-support platform among U S physicians, today announced the launch of Coding Intelligence™ to automate the coding process and capture missing reimbursement, allowing physicians to focus on their patients
OpenEvidence and Tandem Partner to Streamline Evidence-Based . . . OpenEvidence powers the clinical decision backed by evidence and Tandem automates every step from prescription to patient MIAMI, FL and NEW YORK, NY — April 2, 2026 — OpenEvidence, the leader in AI-powered medical search and clinical decision support, and Tandem, the leader closing the gap between breakthrough medications and patient access, today announced a strategic partnership to
OpenEvidence Partners with Cedars-Sinai to Create Patient-Aware . . . MIAMI, FL — May 20, 2026 — OpenEvidence, the most widely used medical AI and clinical decision making tool among U S physicians, today announced a strategic partnership with Cedars-Sinai Health System, one of the nation’s premier academic health systems serving more than one million patients annually, to integrate patient context from Epic directly within OpenEvidence
National Organization for Rare Disorders and OpenEvidence Partner to . . . NORWELL, Mass , and MIAMI, Fla (March 12, 2026) - The National Organization for Rare Disorders (NORD®) and OpenEvidence today announced a new partnership to expand access to trusted, expert-reviewed rare disease information for clinicians, patients and families
Mount Sinai Health System Collaborates with OpenEvidence to Provide . . . Implementing OpenEvidence provides our pharmacists, nurses, and physicians with a unified, trusted platform for evidence-based decision-making, reinforcing our mission to lead the way in safe and effective clinical AI," said Nicholas Gavin, Vice President, Chief Clinical Innovation Officer of Mount Sinai Health System
NCCN and OpenEvidence Collaborate to Bring Clinical Oncology Guidelines . . . PLYMOUTH MEETING, PA, and MIAMI, FL — Nov 5, 2025 — The National Comprehensive Cancer Network® (NCCN®) and OpenEvidence, the leading AI-powered medical search and decision-support platform, today announced a licensing agreement to make NCCN’s trusted, evidence-based oncology guidelines accessible through OpenEvidence’s medical artificial intelligence technology Through this
OpenEvidence and Veeva Announce Long Term Partnership MIAMI, FL and PLEASANTON, CA — Oct 16, 2025 — OpenEvidence and Veeva Systems (NYSE: VEEV) today announced the formation of a long-term partnership to jointly create and market Open Vista
OpenEvidence Expands Access to AAFP’s Evidence-Based Family Medicine . . . MIAMI, FLORIDA — Today, OpenEvidence announced a partnership with the American Academy of Family Physicians (AAFP) to make the Academy’s flagship publications, American Family Physician and FPM, accessible through OpenEvidence The integration will allow clinicians using OpenEvidence to rapidly surface relevant guidance from these key family medicine publications through intuitive, natural